What To Know
- The Company intends to appoint an interim Chief Financial Officer while it undertakes a search for a new Chief Financial Officer with a proven track record of financial leadership and experience to help Covalon with its next phase of growth.
- “I would like to thank Danny for his contributions to Covalon and we wish him the best in his future endeavors,”.
Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, today announced that Danny Brannagan, its Chief Financial Officer, will be stepping down in January 2022 to pursue other endeavours. The Company intends to appoint an interim Chief Financial Officer while it undertakes a search for a new Chief Financial Officer with a proven track record of financial leadership and experience to help Covalon with its next phase of growth.
“I would like to thank Danny for his contributions to Covalon and we wish him the best in his future endeavors,” said Brian Pedlar, Chief Executive Officer of Covalon.